Developing new medications for children to prevent HIV and related infections
Official title: Expertise in Development of Pediatric Drug Formulations
Funded at Advanced Bioscience Laboratories, INC. · NIH-11079408 · Data updated 2026-11-12
This study is all about making better medicines for kids who are at risk for HIV and related infections, so they can have safe and effective treatments to help them stay healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2030 |
| Funding year | 2024 |
| Award (this year) | $487,868 |
| NIH project number | 75N93023D00001-P00001-759302300003-1 |
| Project ID | NIH-11079408 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include children aged 0-11 years who are at risk for HIV or related infections.
✕Less likely to help
Patients outside the age range of 0-11 years or those not at risk for HIV may not benefit from this research.
What this research studies
This research focuses on creating and improving drug formulations specifically for pediatric patients, particularly those at risk for HIV and related infections. The project aims to support the development of new therapeutic and preventive products through collaboration with academic and private sector partners. By providing essential resources and materials, the research seeks to advance promising drug candidates into clinical testing, ensuring that they are safe and effective for young patients.
Why it matters
Potential benefit: If successful, this research could lead to effective HIV prevention and treatment options tailored for children, improving their health outcomes.
How similar studies have gone: Previous research has shown success in developing pediatric formulations for other conditions, indicating potential for similar advancements in HIV prevention.
Where this research is happening
-
Advanced Bioscience Laboratories, INC.
Kensington, United States Active
Researchers
- Principal investigator: Silvera, Peter — Advanced Bioscience Laboratories, INC.
- Study coordinator: Silvera, Peter
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.